6.94
전일 마감가:
$7.05
열려 있는:
$7
하루 거래량:
939.79K
Relative Volume:
0.38
시가총액:
$787.81M
수익:
-
순이익/손실:
$-144.32M
주가수익비율:
-3.1835
EPS:
-2.18
순현금흐름:
$-105.21M
1주 성능:
-5.09%
1개월 성능:
+21.83%
6개월 성능:
+35.34%
1년 성능:
+72.20%
Compass Pathways Plc Adr Stock (CMPS) Company Profile
명칭
Compass Pathways Plc Adr
전화
1-716-676-6461
주소
3RD FLOOR, 1 ASHLEY ROAD, CHESIRE
Compare CMPS vs HCA, THC, FMS, ENSG, UHS
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
CMPS
Compass Pathways Plc Adr
|
6.94 | 800.30M | 0 | -144.32M | -105.21M | -2.18 |
|
HCA
Hca Healthcare Inc
|
527.90 | 121.74B | 75.60B | 7.78B | 7.69B | 28.38 |
|
THC
Tenet Healthcare Corp
|
238.54 | 21.29B | 20.69B | 2.40B | 1.55B | 15.62 |
|
FMS
Fresenius Medical Care Ag Adr
|
23.06 | 12.86B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
ENSG
Ensign Group Inc
|
205.58 | 12.32B | 4.11B | 239.98M | 193.10M | 4.12 |
|
UHS
Universal Health Services Inc
|
195.37 | 12.36B | 16.08B | 1.20B | 1.06B | 17.82 |
Compass Pathways Plc Adr Stock (CMPS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-10 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2025-06-23 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2025-02-27 | 개시 | Stifel | Buy |
| 2024-07-23 | 개시 | RBC Capital Mkts | Outperform |
| 2024-04-01 | 개시 | Morgan Stanley | Overweight |
| 2023-12-12 | 개시 | Deutsche Bank | Buy |
| 2022-11-21 | 재개 | Berenberg | Buy |
| 2022-11-01 | 개시 | Loop Capital | Buy |
| 2021-10-29 | 개시 | Oppenheimer | Outperform |
| 2021-07-13 | 개시 | Citigroup | Buy |
| 2021-06-28 | 개시 | Maxim Group | Buy |
| 2021-05-11 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-04-01 | 개시 | ROTH Capital | Buy |
| 2020-10-14 | 개시 | H.C. Wainwright | Buy |
| 2020-10-13 | 개시 | Berenberg | Buy |
| 2020-10-13 | 개시 | Canaccord Genuity | Buy |
| 2020-10-13 | 개시 | Cowen | Outperform |
| 2020-10-13 | 개시 | Evercore ISI | Outperform |
모두보기
Compass Pathways Plc Adr 주식(CMPS)의 최신 뉴스
HC Wainwright Lifts Earnings Estimates for Compass Pathways - MarketBeat
Propel Bio Management LLC Makes New $2.92 Million Investment in Compass Pathways PLC Sponsored ADR $CMPS - MarketBeat
ARK Investment Management LLC Buys 471,897 Shares of Compass Pathways PLC Sponsored ADR $CMPS - MarketBeat
FY2030 Earnings Forecast for CMPS Issued By HC Wainwright - MarketBeat
Psychedelic Medicine Advances: Here Are Five Companies Targeting CNS Disorders - Benzinga
Compass Pathways raises $200M from warrant exercises - Investing.com
Psychedelic Medicine Advances: Here Are Five Companies Targeting CNS Disorders - Sahm
Compass Pathways (NASDAQ:CMPS) Stock Price Down 6.9%Here's Why - MarketBeat
Sonoco Products posts upbeat Q4 earnings, joins Compass Pathways, Masimo, Itron and other big stocks moving higher on Tuesday - MSN
Are Medical Stocks Lagging Auna S.A. (AUNA) This Year? - Bitget
Magic Mushrooms, Hard Cash: Compass Pathways’ Trial Win, Fast Raise - MarketBeat
Cathie Wood’s ARK sells DraftKings stock, buys Figma and Compass Pathways - Investing.com South Africa
Analysts Bullish on COMPASS Pathways plc (CMPS) Following Psychedelics Symposium and Model Updates - Finviz
Compass Pathways prices $150 million public offering of ADSs By Investing.com - Investing.com South Africa
Compass Pathways prices $150 million public offering of ADSs - Investing.com
Compass Pathways announces $150 million ADS offering - Investing.com India
Compass Pathways (NASDAQ:CMPS) Shares Gap UpShould You Buy? - MarketBeat
Rezolve AI PLC (NASDAQ:RZLV) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Mister Car Wash, Inc. (NYSE:MCW) Given Consensus Rating of “Hold” by Analysts - Defense World
COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
Compass Pathways announces $150 million ADS offering By Investing.com - Investing.com UK
COMPASS Pathways touts Phase III psilocybin wins in TRD, eyes FDA NDA and expedited review - Yahoo Finance
Sonoco Products Posts Upbeat Q4 Earnings, Joins Compass Pathways, Masimo, Itron And Other Big Stocks Moving Higher On Tuesday - Benzinga
Compass Pathways stock soars after positive Phase 3 trial results By Investing.com - Investing.com India
Compass Pathways stock soars after positive Phase 3 trial results - Investing.com
Compass Pathways reports positive phase 3 results for depression drug - Investing.com
Why ZIM Integrated Shipping Shares Are Trading Higher By Around 38%; Here Are 20 Stocks Moving Premarket - Sahm
COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) Short Interest Update - Defense World
Compass Pathways to release new clinical data on psilocybin trials - Investing.com India
Compass Pathways to release new clinical data on psilocybin trials By Investing.com - Investing.com South Africa
What is Lifesci Capital’s Estimate for CMPS FY2025 Earnings? - Defense World
COMPASS Pathways Plc ADR (CMPS) Price Forecast: Bullish Reversal Gains Structure - FXEmpire
COMPASS Pathways plc's (NASDAQ:CMPS) institutional investors lost 16% over the past week but have profited from longer-term gains - Sahm
COMPASS Pathways (NASDAQ:CMPS) Stock Price Down 7.6%Should You Sell? - MarketBeat
Green Plains, Inc. (NASDAQ:GPRE) Given Average Rating of “Hold” by Analysts - Defense World
Nuclear Stocks To Watch Today – January 22nd - Defense World
COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
Expand Energy Corporation (NASDAQ:EXE) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Investors Buy Large Volume of COMPASS Pathways Call Options (NASDAQ:CMPS) - Defense World
COMPASS Pathways Target of Unusually High Options Trading (NASDAQ:CMPS) - MarketBeat
COMPASS Pathways (NASDAQ:CMPS) Trading Down 5.5%What's Next? - MarketBeat
Commonwealth Equity Services LLC Boosts Position in Fidelity Enhanced Emerging Markets ETF $FEMR - Defense World
CMPS: COMP360 is poised to transform TRD and PTSD care with rapid, durable efficacy and broad support - TradingView — Track All Markets
CMPS: COMP360 is set to transform psychiatric care for PTSD and TRD with rapid, durable outcomes - TradingView — Track All Markets
COMPASS Pathways (NASDAQ:CMPS) Sets New 1-Year HighShould You Buy? - MarketBeat
CMPS: COMP360 demonstrates rapid, durable efficacy in TRD and PTSD, supporting near-term commercialization - TradingView — Track All Markets
Compass Pathways stock rises after FDA accepts IND for PTSD treatment By Investing.com - Investing.com South Africa
Compass Pathways stock rises after FDA accepts IND for PTSD treatment - Investing.com
Compass Pathways (Nasdaq:CMPS) Enters Strategic Collaboration with Radial Health - Kalkine Media
Compass Pathways forms seventh strategic collaboration with Radial Health By Investing.com - Investing.com India
Compass Pathways Plc Adr (CMPS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):